Hyperglycemia-induced activation of PKC and/or suppression of CaMKII and calcineurin might therefore contribute to impaired activity and binding of NFAT1 and CEBPβ to target the Igf1 gene promoter. This evidence concerns the gene CAMK2G and Hyperglycemia.